What sector does Sudeep Pharma Limited belong to?

Sudeep Pharma Limited operates in the Healthcare sector, specifically the Pharmaceuticals industry, and is listed on the NSE.

What is the current share price of SUDEEPPHRM?

As of the latest available quote, SUDEEPPHRM traded at ₹1,212.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of SUDEEPPHRM?

Sudeep Pharma Limited has a price-to-earnings (P/E) ratio of about 75.19. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of SUDEEPPHRM?

The market capitalisation of Sudeep Pharma Limited is approximately ₹13,585 Cr.

Is Sudeep Pharma Limited profitable?

For its latest reported financial year, Sudeep Pharma Limited recorded a net profit margin of about 27.10%.

Does SUDEEPPHRM pay a dividend?

Sudeep Pharma Limited currently has a dividend yield of about 0.12%.

What is the return on equity (ROE) of SUDEEPPHRM?

Sudeep Pharma Limited has a return on equity (ROE) of about 25.20%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of SUDEEPPHRM?

Over the past 52 weeks, SUDEEPPHRM has traded between a low of ₹524.05 and a high of ₹1,378.00.

Sudeep Pharma Limited

SUDEEPPHRM NSE Healthcare Pharmaceuticals

Microcap 250

₹1,212.00

-0.12%

Delayed · cached 15 min

Fair value analysis

SUDEEPPHRM

Sudeep Pharma Limited

₹1,213.50

Close used for this calculation

₹389.59Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

35/100

Profitability12/25

Returns10/25

Balance Sheet11/25

Efficiency2/25

Growth0/25

Average

Quality radar

Consensus fair value

₹389.59

Above FV

▼ -67.9% against the close used

Model range ₹169.38 – ₹546.57

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹169.38Fair value₹389.59Bull₹546.57

FairClose

52-week traded range

52W low ₹530.0052W high ₹1,344.20

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Sudeep Pharma Limited closed at ₹1,213.50, 211.5% above the consensus fair value of ₹389.59 drawn from 7 valuation models.

Financial DNA score 35/100 — Average. P/E of 74.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹286.95

-76.4%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹169.38

-86.0%

√(22.5 × EPS × BVPS)

EPS=15.31, BVPS=83.29 · outside Graham range (P/E 74.4, P/B 14.6) — asset-light, treat as a rough floor

P/E Fair Value

₹546.57

-55.0%

EPS × 35.7x (sector P/E)

EPS=15.31, Sector P/E=35.7x

EV/EBITDA

₹199.20

-83.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=2.38B

Book Value (P/B)

₹264.14

-78.2%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=83.29, ROE=25.2%, g=3%, r=10%

Reverse DCF

₹1,213.50

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 25.9% | Historical: 0%

Margin of Safety

₹250.73

-79.3%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=334.3, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer